Table 8.
Comparison between T1DM participants and T2DM participants
| T1DM (N = 228) | T2DM (N = 58) | ||||||
|---|---|---|---|---|---|---|---|
| N (%) / Median (IQR) |
N (%) / Median (IQR) |
p value | Effect size | ||||
| BMI | 22.13 (19.96–24.92) | 26.98 (22.75–30.06) | ***<0.001u | 0.340 (low) | |||
| Laboratory parameters | |||||||
| HbA1c | 7.75 (6.9–8.7) | 7.90 (6.83-9.00) | 0.687u | 0.024 (very low) | |||
| Ur | 5.05 (4.2–6.08) | 5.25 (4.48–7.50) | 0.086u | 0.102 (very low) | |||
| Cr | 70 (59.25-79) |
76.00 (59.75–90.75) |
0.058u | 0.112 (very low) | |||
| ALP | 70.5 (58–87) |
71.50 (56.75-89.00) |
0.978u | 0.002(very low) | |||
| ALT | 17 (12–25) |
26.00 (15.00-39.25) |
***<0.001u | 0.216 (low) | |||
| FG | 8.4 (6.13–10.9) | 7.55 (6.48–10.95) | 0.999u | < 0.001(very low) | |||
| TG | 0.8 (0.6-1) | 1.30 (0.78-2.00) | ***<0.001u | 0.308 (low) | |||
| Chol | 4.5 (3.9–5.1) | 4.40 (3.70-5.00) | 0.302u | 0.061(very low) | |||
| HDL | 1.6 (1.3–1.9) | 1.20 (1.00-1.43) | ***<0.001u | 0.341 (low) | |||
| LDL | 2.5 (2-2.8) | 2.40 (1.90–2.95) | 0.526u | 0.038(very low) | |||
| DKA status | **0.005f | 0.227 (Large) | |||||
| Nil | 111 (48.7%) | 44 (75.9%) | |||||
| DKA at onset | 56 (24.6%) | 5 (8.6%) | |||||
| Impending DKA | 10 (4.4%) | 2 (3.4%) | |||||
| DKA | 47 (20.6%) | 7 (12.1%) | |||||
| Repeated DKA | 4 (1.8%) | 0 (0%) | |||||
| Complications | 0.055c | 0.114 (Small) | |||||
| No | 77 (33.8%) | 12 (20.7%) | |||||
| Yes | 151 (66.2%) | 46 (79.3%) | |||||
| CB-SCID-I/P (H) | 0.208f | 0.085 (Negligible) | |||||
| SCID (H) -ve | 213 (93.4%) | 57 (98.3%) | |||||
| SCID (H) + ve | 15 (6.6%) | 1 (1.7%) | |||||
Note: ***p
**p
, *p
0.05. Continuous variables are analysed by the t independent-samples t test or u Mann‒Whitney U test. Categorical variables were analysed by the c Pearson chi-square test or f Fisher’s exact test. Effect size: Cramer’s V (Categorical variables), Rosenthal correlation (Continuous variables with 2 groups comparison), Epsilon square (Continuous variables with multiple groups comparison)